English
简体中文
繁體中文
客服热线:400-1616-289
登录
注册
会议论文
Tyrosine kinase inhibitors and/or immune checkpoint inhibitors is required for improving efficacy of transarterial chemoembolization for hepatocellular carcinoma: A large-scale multicenter real-world study of 582 patients
Yuan, G.; Li, R.; Zang, M.; Li, Q.; Hu, X.; Fan, W.; Huang, W.; Ruan, J.; Pang, H.; Chen, J.
南方医科大学; 浙江大学; 中山大学; 1
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO)
2022-9
DOI: 10.1016/j.annonc.2022.07.843
6
阅读
引用
收藏
分享
相关
加载中…
文献加载失败,请重试
重试